|
 Melbourne set for COVID lockdown exit despite record cases
Melbourne will exit months of COVID-19 lockdown next week, helped by
a faster-than-expected vaccine uptake, Victoria state Premier Daniel
Andrews said on Thursday, ahead of schedule even though daily
infections hit a record the same day.
On the worst day of a Delta variant outbreak that began in early
August, Victoria logged 2,297 new cases, up from 1,571 the day
before and the highest for any Australian state or territory since
the pandemic began. Eleven people died, bringing the total toll in
the latest outbreak to 125.
Indonesia's Bali reopens to international tourists, but with no
flights
Indonesia's holiday island of Bali reopened to foreign tourists
after 18 months of pandemic hiatus on Thursday, but the island is
lacking one crucial ingredient: international flights. Though the
island's Ngurah Rai International Airport has carried out
simulations preparing for tourists to return, it is not expecting
much to happen soon.
Details about the reopening, such as visa requirements and which
countries they apply to, have so far been patchy. Indonesia late on
Wednesday had confirmed the 19 eligible countries, which include
China, India, Japan, South Korea and New Zealand, and several
countries from Western Europe and the Arabian Gulf.
J&J shot gets better boost from Moderna or Pfizer in NIH study
People who got Johnson & Johnson Inc's COVID-19 vaccine as a first
shot had a stronger immune response when boosted with vaccines from
Pfizer Inc/BioNTech SE or Moderna Inc, a study run by the National
Institutes of Health showed on Wednesday. The preliminary study
hasn't been peer-reviewed and is the latest challenge to J&J's
efforts to use its vaccine as a booster in the United States.
[to top of second column] |
 More than 450 adults who
received initial shots from Pfizer, Moderna, or
Johnson & Johnson were part of the study that
showed "mixing and matching" booster shots of
different types is safe in adults. Moderna's and
Pfizer's vaccines are based on messenger RNA,
while J&J's uses viral vector technology.
Separately, officials on Wednesday said J&J's
regulatory submission for its planned booster
raised red flags, including small sample sizes
and data based on tests not yet validated.
English school return spurred COVID in children
COVID-19 infections in children in England rose in September after
schools returned from summer holidays, helping to keep cases high
even as there was a fall among adults, a large prevalence study
showed on Thursday. The study found that the
epidemic was growing among those under 17, with an estimated
reproduction "R" number of 1.18. An R number above 1 implies
exponential growth, while a number below 1 implies the epidemic is
shrinking. The epidemic was estimated to be shrinking in 18- to
54-year-olds, while it was broadly steady among those over 55.
India resumes vaccine exports as domestic stocks build up -
officials
India has resumed a small number of COVID-19 vaccine exports and
will increase exports significantly in the next few months as
domestic stocks build up and most of its large population is
inoculated, officials said on Wednesday.
So far about 4 million shots have been exported, the source said, a
small amount in proportion to the expansive vaccine diplomacy Prime
Minister Narendra Modi's government launched this year before a
second wave of infections forced a halt.
(Compiled by Karishma Singh; Editing by Ramakrishnan M.)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
